Join us in Indianapolis for a full day of presentations by the nation’s top experts in Hematology and Hematologic Malignancies. Participants will have the opportunity to interact with these thought leaders in several panel discussions. This annual hematology review is one of the most comprehensive, educational hematology conferences in the country. Our exceptional faculty will provide a concise and practical summary of the American Society of Hematology annual meeting, presenting the most current hematology research and clinical practice.

This symposium convenes oncology professionals, researchers, and policy advocates to explore the current challenges and strategic solutions in advancing inclusive excellence across the cancer research continuum. Attendees will engage with thought leaders discussing policy-aligned models for accountability, tools for building diversity plans into clinical trial design, and methods for standardizing demographic reporting in academic publications.

With a focus on practical implementation, the DRIVE Initiative offers a blueprint to help institutions, sponsors, and investigators align with regulatory guidance, such as the U.S. FDORA Act of 2022, while advocating for its broader international adoption. This is more than an academic discussion; it's a call to action for stakeholders committed to advancing equitable outcomes in cancer care and research.

A free, half day of presentations for community oncologists, preceding our annual “Indy Hematology Review”.

Innovative immune effector therapies, including CAR T-cell and bi-specific antibody treatments, have transformed cancer care but remain largely inaccessible to community oncology practices. Our Network is dedicated to bridging this gap by establishing the necessary infrastructure, protocols, and training to safely and effectively administer these lifesaving therapies in community settings. By promoting equitable access, fostering clinical trial participation, and supporting diverse patient populations, we aim to reduce disparities and expand the reach of modern cellular therapies.

The purpose of this is to invite trainees in medical oncology and hematology from across the nation to attend our conference and to have access to our esteemed international faculty. The goal of our conference is to promote education, interaction, networking, and an opportunity to look toward the future including potential employment for our trainees. IHE will be providing an overnight room to fellows in order to facilitate the ability of our trainees to attend this conference.